|
|
|
Summary
of 1993 CPCRA Posters and Presentations
| 14th Annual Meeting of the Society for Clinical Trials, May 1-4, 1993 |
Church T, Dehlinger M, Saravolatz LD, Stein D, Winslow D, Collins G. Design of a Randomized Trial of Combined Nucleoside Analog Antiretroviral Therapy in AIDS Patients. Poster.
abstract
| ALA/ATS International Conference, May 16-20, 1993, San Francisco, CA |
Gordin F, Thompson C, Matts J, Muth K, Korvick J, Deyton LR. The Utility of Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection. Poster. CPCRA 008 TB/Booster.
abstract
| 51st Annual Meeting of the United States Mexico Border Health Association (USMBHA) Pan American Health Organization (PAHO), June 6-9, 1993, Albuquerque, New Mexico |
Salvador G, Bolden B, Brown H, Crespo J, Podhurst L, Tobin JN, Vaughn A. HIV+/AIDS Latinos Enrolled in Clinical Trials: A Report from Two Primary Care Community Health Centers in Newark, New Jersey. Poster.
abstract
| IX International Conference on AIDS, June 7-11, 1993, Berlin, Germany |
Thompson C, Gordin F, Muth K, Daniels K, Matts J, Maiatico G, Deyton LR. Two-Stage
Tuberculin (PPD) Skin Testing in Individuals With HIV Infection. Poster. CPCRA 004
TB/PPD+.
abstract
El-Sadr W, Wentworth D, Dehlinger M, Larntz K. Design and Implementation of a
Community-Based Trial for Prophylaxis for P. Carinii Pneumonia (PCP). Poster.
abstract
Wentworth D, Neaton J, Luskin-Hawk R, Perez G, Taylor V, Deyton LR. Design and Logistical
Features of a Large, Simple Trial in AIDS. Poster
abstract
Fuentes L, El-Sadr W, Guity C, Quint E, Capps L. A Preliminary Assessment of the Degree of
Integration of Community-Based Physicians in Clinical Trials for HIV. Oral.
abstract
Abrams DI, Goldman A, Launer C, Korvick J, Crane LR, Deyton LR. Results of a Randomized
Open-Label Comparison Trial of ddI and ddC in HIV-Infected Patients Who Are Intolerant of or
Have Failed ZDV Therapy. Oral. CPCRA 002 DDI/DDC
abstract
Walker J, Pablovich S, Besch CL. Successful Implementation of Standardized Tuberculosis(TB) Skin Testing and Recruitment to Related Protocols. Poster.
abstract
Neaton J, Wentworth D, Rhame F, Hogan C. Is Disease Progression the Optimal Endpoint for
AIDS Clinical Trials? Oral.
Church T, Horsburgh CR, Brelje T, Cohn D, Gibert C. Effects of Disseminated Mycobacterium
avium Complex and Its Treatment on Survival of AIDS Patients: An Observational Study.
Poster.
abstract
Loveless M, Sherer R, Crane LR, Neaton J. The Impact of Prior Oral Imidazole Therapy on
HIV-Associated Cryptococcal Infection. Poster. CPCRA 003 ODB.
abstract
Bacheler L, Ackerman K, Sheridan P, Pachl C, Swanson K, Winslow. Quantitation of HIV
Plasma Viremia Using the Branched DNA Signal Amplification and P24 Antigen Assays During
Combination Nucleoside Antiviral Therapy. Poster. CPCRA 007 NuCombo.
abstract
| 5th International Social Work and AIDS Conference, June 23-25, 1993, San Francisco, CA |
Cox LE, Markowitz M, Rouff J. Community Advisory Boards: A Communication Bridge in AIDS Research. Oral.
abstract
| Joint Statistical Meetings, August 15, 1993, San Francisco, CA |
Neaton J, Wentworth D. Statistical Design Considerations For a Large, Simple Trial (LST) on Timing of Combination Nucleoside Treatment. Oral.
Neaton J, Wentworth D. The Design and Phase-in of a Large, Simple Trial in HIV Disease. A Unique Plan for Data Collection. Oral.
| VIIIth International Conference on AIDS in Africa & VIIIth African Conference on STDs, August 31, 1993 |
Schuman P, Goldman A, Peng G, Korvick J, Costanzo L, Kerkering T. The First 261 Enrollees in the Women’s Fungal Prophylaxis Study. Poster. CPCRA 010, Women’s Fungal.
abstract
| VI Annual AIDS Update Conference, October 19-23, 1993, San Francisco, California |
Bolden B, Brown H. Factors Influencing Participation in Clinical Trials. Printed.
| 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), October 17-20, 1993, New Orleans, LA |
Irvin K, Finley E, Matts J, Nelson E, Dratter V, Gordin F. Rate of Tuberculosis (TB) Infection Among Health Care Workers (HCWs) Providing Care to HIV+ Populations. Oral.
abstract
El-Sadr W, Wentworth D, Neaton J. Ordered Risk by CD4 for Opportunistic Infections (OIs) in HIV-Infected Patients (pts). Poster.
abstract
Burns D, Hillman D, Gordin F, Sherer R, Neaton J. Smoking and HIV-1 Infection: Demographic Characteristics, CD4+ Levels, and Clinical Outcomes in a Large, Community-Based Cohort. Oral.
abstract
| American Public Health Association (APHA) 121st Annual Meeting, October 24-28, 1993, San Francisco, CA |
Brown Jr LS, Neaton J, Wentworth D, Sherer R, Besch CL. Injection Drug Users (IDUs) and Non-IDUs: Are There Differences in HIV Disease Progression and Survival? Oral.
abstract
|
|
|
